Patent ID: 9028827
Filing Date: 2015-05-12
Classification: A61K,A61P,C07K

Abstract:
1. A method for reducing viral titer in a subject infected with hepatitis C virus (HCV) or hepatitis B virus (HBV), comprising administering to the subject a composition comprising (a) a first composition comprising a yolk obtained from an egg of a fowl which has been immunized using Helicobacter pylori together with Phellinus baumii and chitosan, and (b) a second composition comprising Salviae Miltiorrhiza Radix, Oldennlandiae Hb., Zingiberis Radix, Ginseng Radix, Atractylodis Radix, Curcumae Radix, Angelicae Sinensis Radix, bee propolis, calcium lactate, soy proteins, probiotics, and grain bran, in an amount effective to reduce viral titer in the subject.